4//SEC Filing
Halladay Benjamin 4
Accession 0001628280-25-013198
CIK 0001434868other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:16 PM ET
Size
20.2 KB
Accession
0001628280-25-013198
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Award
Common Stock
2025-03-14+238,000→ 485,245 total - Award
Stock Option (right to buy)
2025-03-14+213,000→ 213,000 totalExercise: $1.50Exp: 2035-03-14→ Common Stock (213,000 underlying)
Footnotes (2)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be in June 15, 2025.
- [F2]Includes 6,574 shares recently acquired in Esperion's Employee Stock Purchase Plan.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001953943
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 5:16 PM ET
- Size
- 20.2 KB